Ibrutinib Combined With Obinutuzumab and Venetoclax for Treatment-Naive Older Patients With CLL from obinutuzumab and venetoclax in cll Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Your browser does not support playing the video.Please download the video!
Description: Jennifer Ann Woyach, MD, shares data on ibrutinib combined with obinutuzumab and venetoclax vs ibrutinib plus obinutuzumab for the frontline treatment of older patients with CLL in the setting of the COVID-19 pandemic.